China Jo-Jo Drugstores Announces $2.625 Million Registered Direct Offering

Rhea-AI Summary

China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) announced a registered direct offering of 1.75 million ordinary shares at $1.50 each, generating gross proceeds of $2.625 million. Alongside this, the company will issue warrants for 5.25 million shares with an exercise price of $2.50, valid for three years. The closing of this offering is anticipated on January 24, 2023, pending standard conditions. The proceeds will be used for general corporate purposes and working capital. The offering is made under a shelf registration statement effective December 19, 2022.

Positive

• Gross proceeds of $2.625 million, enhancing liquidity.
• Warrants allow potential for additional capital through future share exercise.

Negative

• Issuance of new shares may lead to shareholder dilution.
• Current share price below offering price suggests market skepticism.

News Market Reaction – CJJD

+12.85%

+12.85% Session move

In the trading session that priced this news, CJJD gained 12.85%, reflecting a significant positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

HANGZHOU, China, Jan. 20, 2023 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1.75 million ordinary shares, at a purchase price of $1.50 per share, in a registered direct offering for aggregate gross proceeds of $2.625 million. Jo-Jo Drugstores also agreed to issue to the investors registered warrants to purchase up to 5.25 million ordinary shares. The warrants will have a term of three years, be exercisable immediately at an exercise price of $2.50 per share. The closing of the sale of the securities is expected to occur on or about January 24, 2023, subject to satisfaction of customary closing conditions.

Jo-Jo Drugstores intends to use the net proceeds from the offering for general corporate purposes and working capital.

The ordinary shares and warrants described above are being offered pursuant to a "shelf" registration statement on Form F-3 (File No. 333-259692), which was declared effective by the United States Securities and Exchange Commission (the "SEC") on December 19, 2022. The ordinary shares and warrants described above may be offered only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. When filed with the SEC, copies of the final prospectus supplement and the accompanying prospectus relating to the registered direct offering may be obtained at the SEC's website at http://www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About China Jo-Jo Drugstores, Inc.

China Jo-Jo Drugstores, Inc. ("Jo-Jo Drugstores" or the "Company"), is a leading online and offline retailer and wholesale distributor of pharmaceutical and other healthcare products and a provider of healthcare services in China. Jo-Jo Drugstores currently operates an online pharmacy and retail drugstores with licensed doctors on site for consultation, examination and treatment of common ailments at scheduled hours. It is also a wholesale distributor of products similar to those carried in its pharmacies. For more information about the Company, please visit http://jiuzhou360.com. The Company routinely posts important information on its website.

Forward-Looking Statements

This press release contains information about the Company's view of its future expectations, plans and prospects that constitute forward-looking statements. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with its ability to raise additional funding, its ability to maintain and grow its business, variability of operating results, its ability to maintain and enhance its brand, its development and introduction of new products and services, the successful integration of acquired companies, technologies and assets into its portfolio of products and services, marketing and other business development initiatives, competition in the industry, general government regulation, economic conditions, dependence on key personnel, the ability to attract, hire and retain personnel who possess the technical skills and experience necessary to meet the requirements of its clients, and its ability to protect its intellectual property. The Company's encourages you to review other factors that may affect its future results in the Company's annual reports and in its other filings with the Securities and Exchange Commission.

For more information, please contact:

Company Contact: 

Frank Zhao
Chief Financial Officer
+86-571-88077108
frank.zhao@jojodrugstores.com

Investor Relations Contact:

Tina Xiao
Ascent Investor Relations LLC
+1-917-609-0333
tina.xiao@ascent-ir.com

View original content:https://www.prnewswire.com/news-releases/china-jo-jo-drugstores-announces-2-625-million-registered-direct-offering-301726561.html

SOURCE China Jo-Jo Drugstores, Inc.

FAQ

What is the purpose of China Jo-Jo Drugstores' $2.625 million offering?

The proceeds are intended for general corporate purposes and working capital.

When will the offering by China Jo-Jo Drugstores close?

The closing of the sale is expected on January 24, 2023.

What are the exercise terms of the warrants issued by CJJD?

The warrants are exercisable immediately at an exercise price of $2.50 per share and have a three-year term.

How many shares did China Jo-Jo Drugstores issue in this offering?

They issued 1.75 million ordinary shares.

What was the pricing of the shares in the CJJD offering?

The shares were priced at $1.50 each.